PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 14, 2026SHILAP Revista de lepidopterología0 citationsOpen Access

SARS-CoV-2 Mpro inhibitors from Siphonostegia chinensis: an integrated biophysical and computational study

YRYingjie RenHenan University of Traditional Chinese MedicineWWWei WangFirst Affiliated Hospital of Henan University of Traditional Chinese MedicineDZD. H. ZhangHenan University of Traditional Chinese Medicine

Key Points

  • The aim is to identify active compounds in Siphonostegia chinensis that inhibit SARS-CoV-2 Mpro.
  • Preliminary screening of Siphonostegia chinensis for antiviral activity.
  • Utilization of bio-layer interferometry and UPLC-QTOF-MS for compound identification.
  • In vitro enzymatic assays to determine inhibitory effects and binding affinities.
  • Molecular docking and dynamics simulations to elucidate binding mechanisms.
  • ADMET predictions for assessing drug-likeness.
  • Identified verbascoside and 3,4-dicaffeoylquinic acid as potent Mpro inhibitors.
  • Binding affinities measured at 2.149 × 10−6 M and 2.487 × 10−5 M respectively.
  • Demonstrated IC50 values of 0.076 µM and 0.194 µM in enzymatic inhibition assays.
  • Molecular simulations revealed stable interactions within Mpro's catalytic pocket.
  • ADMET predictions indicate favorable drug-like properties.

Abstract

Background The COVID-19 pandemic caused by SARS-CoV-2 underscores the urgent need for novel antiviral agents. Preliminary screening indicated that the traditional Chinese medicine Siphonostegia chinensis Benth. (Bei Liu Ji Nu) possesses inhibitory activity against the SARS-CoV-2 main protease (Mpro), a key enzyme for viral replication. Methods To identify the active constituents responsible for its anti-SARS-CoV-2 activity, we employed an integrated strategy combining bio-layer interferometry (BLI) and ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). Results Two phenolic compounds, verbascoside and 3,4-dicaffeoylquinic acid, were successfully fished out and identified from the ethanol extract as the most potent binders to Mpro. The binding affinities (KD) were determined to be 2.149 × 10 −6 M and 2.487 × 10 −5 M, respectively. Subsequent in vitro enzymatic inhibition assays confirmed their inhibitory effects, with IC 50 values of 0.076 µM and 0.194 µM, respectively. To elucidate the inhibition mechanism, molecular docking and molecular dynamics simulations were performed, revealing stable binding modes of both compounds within the catalytic pocket of Mpro through key interactions. Preliminary ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) predictions were also conducted to assess their drug-likeness. Conclusion Our findings demonstrate that verbascoside and 3,4-dicaffeoylquinic acid exhibit high binding affinity and structural stability against SARS-CoV-2 Mpro, highlighting their potential as lead compounds for inhibiting viral replication. Furthermore, the comprehensive strategy established in this study provides a reliable and efficient approach for identifying bioactive components from complex herbal matrices, offering new perspectives and a scientific basis for the development of natural product-derived targeted therapeutics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ren et al. (2026) studied this question.

synapsesocial.com/papers/69ddd8eee195c95cdefd663ahttps://doi.org/10.3389/fchem.2026.1790228
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine2024 · 10 citations
  2. 2Discovery of Novel Natural Inhibitors Against SARS-CoV-2 Main Protease: A Rational Approach to Antiviral Therapeutics2024 · 3 citations
  3. 3Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy2026
  4. 4Molecular Docking and Simulation Analysis: Uncover Potential Phytochemical Inhibitors of the SARS-CoV-2 Main Protease2025
  5. 5Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform2024 · 3 citations